Leica Biosystems and Indica Labs Partner to Develop AI-Driven Digital Pathology Platform
Leica Biosystems and Indica Labs will develop a next-gen digital pathology platform and accelerate AI-enabled CDx for cancer care.
Leica Biosystems and Indica Labs will develop a next-gen digital pathology platform and accelerate AI-enabled CDx for cancer care.
The FDA clearance enables US healthcare providers to use Sectra’s digital pathology solution for primary diagnostics.
The system supports mobile management of anatomic pathology labs using cloud computing and smart mobile devices.